The contribution of nitric oxide (NO) to exercise-induced hyperemia is debated. Previous conclusions that nitric oxide synthase (NOS) inhibition reduces endothelium-dependent vasodilation during exercise hyperemia may be confounded by inhibitor-mediated increases in resting vascular tone. In this study, nine healthy participants performed wrist exion exercise before and during intra-arterial administration of the NOS-inhibitor N G -monomethyl-l-arginine (l-NMMA, 2 mg·min -1 ). Nine additional subjects performed this procedure while nitroprusside (0.2 mg·min -1 ) was co-infused with l-NMMA to maintain basal ow. Forearm blood ow was assessed with venous occlusion strain-gauge plethysmography at baseline, immediately after cessation of exercise, and continuously for 5 minutes thereafter. l-NMMA alone reduced resting ow by 26%, peak ow immediately after exercise by 20%, and integrated post-exercise hyperemic volume by 50% (all p , 0.05). Stabilization of resting vasodilator tone by nitroprusside eliminated the effects of l-NMMA on peak ow after exercise, yet l-NMMA still attenuated total hyperemic volume. In a time-control study of 12 subjects, there was no change in peak blood ow or hyperemic volume. This study indicates that NO is not a major regulator of peak limb blood ow measured immediately after cessation of dynamic exercise. The contribution of NO to exercise hyperemia is limited to the recovery period after exercise.
Introduction
Dynamic exercise augments metabolic demand in human skeletal muscle, and blood ow increases to supply adequate nutrients to the active tissue. The regulation of the hyperemic response to exercise is complex and incompletely understood. A number of neuronal, metabolic, endothelium-derived, and mechanical factors have been implicated in vasoregulation during and after exercise. 1 One of these is endothelium-derived nitric oxide, a major contributor to resting vascular tone. 2 Investigations of the contribution of nitric oxide (NO) to exercise-induced hyperemia have produced con icting results in both animal and human models. In some isolated muscle preparations, nitric oxide synthase (NOS) inhibition reduced resting ow, but did not reduce ow during electrically stimulated contractions, whereas in others NOS inhibition did reduce dilation during induced contraction. 3 -5 Studies using awake, exercising animals agree on a role for NOS in maintaining resting vessel tone, but con ict with respect to a role for NO during exercise. 6 ,7 Several studies in the human forearm have demonstrated a vasoregulatory role for NO at rest, during, and after exercise. 8 -1 1 Others have found that NO does not contribute to hyperemia dur-ing exercise, but may have a vasoregulatory role during the recovery period, 3-5 minutes after cessation of exercise. 1 2 -1 4 These investigations rely on the intra-arterial administration of stereospeci c, competitive NOS inhibitors such as N G -monomethyl-l-arginine (l-NMMA) to block production of NO. In studies positing a vasoregulatory role for NO during exercise, the l-NMMA-mediated decreases in resting forearm blood ow have corresponded to the decreases in forearm blood ow seen during exercise. This occurrence confounds the interpretation of the apparent role of NO during exercise, since reduction in exercise hyperemia may only be a consequence of the decreased baseline vasodilator tone associated with l-NMMA administration, and not speci c for exercise.
To address this concern, this study of isotonic exercise in the human forearm controlled resting blood ow by coinfusing the endothelium-independent vasodilator sodium nitroprusside with l-NMMA before, during, and after the exercise stimulus. By maintaining resting vasodilator tone during l-NMMA administration, it was possible to determine more precisely the contribution of NO to exerciseinduced hyperemia.
Methods

Subjects
The study population included 30 healthy subjects, 15 men and 15 women, ranging in age from 18 to 41 years (mean age 29 6 2 years). Volunteers were screened by history, physical examination, and laboratory evaluation, and were excluded for hypercholesterolemia (de ned as total choles-terol or low-density lipoprotein cholesterol .75th percentile for age and gender), hypertension (.140/90 mmHg), diabetes and medication use. Only one subject identi ed himself as a smoker.
This study was approved by the Human Research Committee of Brigham and Women's Hospital. Each subject provided written, informed consent.
Experimental protocol
Each subject was studied in a quiet, 22°C temperaturecontrolled room in the post-absorptive state. Subjects were instructed to abstain from alcohol, caffeine, and non-steroidal anti-in ammatory drugs for at least 12 hours prior to the study. Using aseptic technique and local anesthesia (Xylocaine 2%), the brachial artery of the non-dominant arm was cannulated with a 1.5-inch, 20-gauge Te on catheter. This arterial line was used for blood pressure determination and for drug administration. All subjects rested for at least 30 minutes after catheter placement to establish a stable baseline prior to data collection. During this time, an isotonic 5% dextrose solution was infused intra-arterially at a rate of 0.4 ml·min -1 .
Baseline hemodynamic measurements included forearm blood ow, blood pressure, and heart rate. Measurements were recorded every 10 minutes until stability was assured.
Contribution of NO to exercise hyperemia
The contribution of NO to exercise-induced forearm blood ow was assessed initially in nine subjects (six males, three females, aged 29 6 4 years). After baseline measurements were completed, acetylcholine (Miochol, Iolab Pharmaceuticals, Claremont, CA, USA) was infused for 5 minutes at a dose of 30 mg·min -1 to evaluate endothelium-dependent vasodilation to a pharmacological stimulus. Hemodynamics were measured during the last 2 minutes of infusion. After 30 minutes without infusion, hemodynamic measurements were repeated every 10 minutes until baseline conditions were re-established. Subjects then performed isotonic forearm exercise consisting of metronome-guided, maximal wrist exion and extension (in a 180°arc) at 60 cycles·min -1 . Hemodynamic measurements were made immediately following completion of exercise for 5 minutes as follows: every 5-10 seconds during the rst minute, every 15 seconds during the second to third minute, and every 30 seconds during the third to fth minute following exercise cessation. Peak ow was de ned as the highest ow achieved within the rst 20 seconds after cessation of exercise. Hyperemic volume was de ned as the area under the curve of ow versus time, and was calculated for the ve minutes after cessation of exercise. Upon completion, subjects rested for 30 minutes.
Subsequently, the competitive NOS antagonist N G -monomethyl-l-arginine (l-NMMA, Clinalfa) was infused into the brachial artery at a dose of 2 mg·min -1 . After 20 minutes, resting hemodynamic measurements were obtained. Acetylcholine was co-administered with l-NMMA to determine the extent of NOS inhibition of the pharmacological stimulus. After return to resting ow, forearm exercise was repeated exactly as described above. The l-NMMA infusion was maintained throughout the exercise Vascular Medicine 2002; 7: 163-168 sequence and recovery period to ensure appropriate distribution to the vascular beds recruited during contractions. 1 5 In uence of resting ow on exercise hyperemia In nine additional subjects (four males, ve females, aged 28 6 2 years) the contribution of NO to exercise-induced forearm blood ow was assessed exactly as above, while controlling for the effect of l-NMMA on resting vascular tone. In these subjects, an endothelium-independent vasodilator, sodium nitroprusside (0.2 mg·min -1 ; Elkins-Sinn Inc., Cherry Hill, NJ, USA), was co-infused with the l-NMMA. This drug combination maintained a consistent resting blood ow at the level recorded prior to the administration of l-NMMA. This technique has been used successfully by this group and others. 1 6 ,1 7 Time-independence of exercise stimulus Twelve additional subjects ( ve males, seven females, aged 28 6 2 years) underwent the identical exercise sequences described above, but did not receive any drug infusions, in order to assess the reproducibility of the exercise stimulus over the course of the experiment.
Hemodynamic measurement
Bilateral forearm blood ow was determined by venous occlusion plethysmography using calibrated mercury-in-Silastic strain gauges (DE Hokanson, Inc., Seattle, WA, USA) placed around the widest portion of the forearm, as previously described. 1 8 Blood pressure cuffs were placed on the wrist and upper arm of both limbs; both arms were supported above the level of the heart. Beginning 20 seconds prior to each forearm blood ow determination, circulation to the hand was prevented by in ating the wrist cuff to suprasystolic pressure. In ation of the upper cuff above venous pressure (average 40 mmHg) allowed measurement of forearm blood ow. Each forearm blood ow determination at rest comprised at least ve separate measurements performed at 10-to 15-second intervals. The average of these measurements is reported, expressed as ml·100 ml tissue -1 ·min -1 . The response to each segment of the protocol was assessed by the forearm blood ow in the infused arm. Drug doses were chosen to avoid systemic effects. To help monitor this, forearm blood ow was also evaluated in the contralateral arm.
Blood pressure was determined using the arterial cannula attached to a Statham P23 pressure transducer (Gould, Inc., Cleveland, OH, USA) aligned to an ampli er on a physiologic recorder (Gould, Inc.). Heart rate determination was made from a simultaneous electrocardiographic signal and calculated from the R-R interval. Forearm vascular resistance was calculated as mean arterial pressure divided by forearm blood ow, and is expressed in units (unit = mmHg·ml -1 ·100 ml tissue -1 ·min -1 ).
Statistical analysis
Results are presented as mean value 6 standard error. Paired two-tailed t-tests were used to compare means before and after infusion of l-NMMA. Sample size was calculated at 80% power to detect a 25% reduction in forearm blood ow by l-NMMA. Statistical signi cance was accepted at the 95% con dence level.
Results
Effect of l-NMMA alone on exercise-induced hyperemia
Resting hemodynamics
The mean baseline forearm blood ow was 2.3 6 0.2 ml·100 ml -1 ·min -1 , and mean forearm vascular resistance was 39.5 6 3.3 units (Table 1) . l-NMMA decreased blood ow by 26% ( Figure 1A) , and increased vascular resistance by 31% (each p , 0.01). Prior to NOS inhibition, acetylcholineinduced forearm blood ow was 8.5 6 0.9 ml·100 ml -1 ·min -1 and vascular resistance was 10.2 6 1.3 units. l-NMMA reduced acetylcholine-mediated increases in resting ow by 35%, and attenuated acetylcholine-mediated decreases in resistance by 67% (both p , 0.001). This degree of NOS inhibition is consistent with prior results from several laboratories. 8 ,9 , 1 1 ,1 8 Neither acetylcholine nor l-NMMA affected forearm blood ow in the contralateral (non-infused) arm, mean blood pressure, or heart rate.
Peak ow after exercise
The peak forearm blood ow response immediately after exercise at 60 cycles·min -1 was 9.3 6 0.8 ml·100 ml -1 ·min -1 , and forearm vascular resistance decreased to 10.4 6 0.9 units. Administration of l-NMMA reduced peak ow after exercise by 20% (p = 0.03; see Figure 1A ), and limited the decreases in resistance (p = 0.05; Table 1 ).
Hyperemic volume in recovery after exercise
The baseline integrated hyperemic response at 5 minutes post-exercise was 15.7 6 3.6 ml·100 ml -1 . l-NMMA administration reduced the hyperemic volume by 50% (p = 0.04; Figure 2 ). Blood pressure and heart rate, both at rest and during exercise, were not affected by the intra-arterial infusion of l-NMMA. 
Effect of l-NMMA with nitroprusside on exerciseinduced hyperemia
Resting hemodynamics
The mean baseline forearm blood ow was 2.4 6 0.3 ml·100 ml -1 ·min -1 , and mean forearm vascular resistance 41.4 6 6.0 units ( Table 2 ). The co-infusion of l-NMMA and nitroprusside maintained both ow and resistance at levels similar to those before NOS inhibition (both p = NS; Figure 1B ). Blood pressure and heart rate did not change.
Peak ow response to exercise
Prior to l-NMMA + nitroprusside, peak forearm blood ow response to wrist exion exercise was 14.4 6 2.0 ml·100 ml -1 ·min -1 ; forearm vascular resistance decreased to 7.4 6 1.1 units ( Table 2 ). This response was somewhat higher than the mean peak response achieved during the rst protocol; this is attributed to normal variations in ow between the two groups of different volunteers. Most important is the response within each group to the subsequent addition of the NOS inhibitor. In this second group of volunteers, during co-infusion of l-NMMA plus nitroprusside the corresponding peak ow and vascular resistance were unchanged (both p = NS; Figure 1B ).
Hyperemic volume in recovery after exercise
Co-infusion of l-NMMA and nitroprusside reduced integrated hyperemic volume in the 5 minutes following exercise cessation by 21% (p = 0.05; Figure 2 ).
Reproducibility of blood ow response to exercise
Twelve subjects underwent a time-control experiment to assess the reproducibility of the blood ow response to exercise. The initial peak forearm blood ow response to exercise was 13.8 6 1.1 ml·100 ml -1 ·min -1 . After the second sequence of exercise, the peak ow was 12.9 6 0.9 ml·100 ml -1 ·min -1 (p = NS). The hyperemic volume determined 5 minutes after cessation of exercise at 60 cycles·min -1 was 17.9 6 2.5 ml·100 ml -1 and 16.3 6 1.7 ml·100 ml -1 after the rst and second sequences (p = NS). 
Discussion
This study demonstrates that the contribution of endotheliumderived NO to exercise-induced hyperemia in the human forearm resistance vessels is limited to the recovery period after dynamic exercise. Endothelium-derived NO does not contribute to the peak blood ow generated by exercise if the vasoconstrictor effect of NOS inhibition on resting arterial tone is eliminated. Previous interpretations of the role of NO in exercise hyperemia have been limited by this confounding effect, which was eliminated in this study by co-infusion of sodium nitroprusside, an endothelium-independent vasodilator, with l-NMMA.
Role of NO in exercise hyperemia
A variety of neural, mechanical, and metabolic factors have been implicated in the regulation of blood ow in human skeletal muscle during dynamic exercise, including cholinergic and adrenergic inputs, the muscle pump, prostacyclin, adenosine, K-ATP channels, and hypoxia. 1 ,1 9 It is clear that NO is an important mediator of resting vascular tone; however, its role in the initiation and maintenance of the hyperemic response to exercise is less well-de ned.
Investigations of the role of NO in exercise-induced hyperemia have yielded contradictory results in both animal and human models. In isolated preparations of rabbit tenuissimus muscle and of canine gastrocnemius muscle, inhibition of NOS reduced resting ow, but did not reduce ow during electrically stimulated contractions. 3 ,4 In a study of isolated hamster cremaster muscle, however, inhibition of NOS resulted in reduced dilation in rst-and second-order arterioles during induced contractions. 5 In these isolated muscle preparations, which rely on electrical stimulation of motor neurons, the experimental active hyperemia may be much less than is normally elicited in vivo. 2 0 Other studies have examined live exercising animals, also with equivocal results. In treadmill-exercised rats, Hirai et al found that NOS inhibition reduced blood ow during exercise in half of the individual hindquarter muscles measured, with greater reductions seen in muscles with a greater proportion of oxidative bers. 6 In contrast, limb blood ow to skeletal muscle and coronary arteries in conscious exercising dogs was unaffected during infusion of a NOS inhibitor. 7 ,2 1 These inconsistencies may be attributed to the variety of muscle groups studied, or the difference in ber-type composition between muscle groups and between species.
Human forearm studies have not yielded a better consensus, with some studies concluding that NO contributes to peak exercise hyperemia 8 -1 1 and others concluding a limited role of NO to the recovery period in the minutes after cessation of exercise 1 4 or no role at all. 1 2 ,1 3 Most recently, Duffy et al investigated forearm blood ow in 25 healthy subjects undergoing dynamic wrist exion exercise, before and after the administration of l-NMMA. In this study, NOS blockade reduced peak blood ow immediately after cessation of exercise by 18%, and also reduced hyperemic volume repaid 1 minute and 5 minutes after cessation of exercise by 25% and 37% respectively. 1 1 However, these reductions are paralleled by l-NMMA-mediated reductions in resting ow of 42%. This result is in agreement with a number of related studies that also showed similar l-NMMA-mediated reductions in resting and hyperemic ow. 8 -1 0 Interestingly, when faced with similar results, Endo et al concluded that given the parallel reductions in resting ow and hyperemic ow, NO must not be an important mediator of exercise hyperemia. 1 3 Duffy et al account for the effect of resting ow reduction by analyzing the absolute increase in ow over baseline levels. 1 1 This assumes, however, a simple linear relationship between resting tone and subsequent changes in vessel caliber, which may not exist. Indeed, it is possible that the very loss of vasodilator tone could limit recruitment of the microcirculation, altering the hyperemic response to exercise. 2 2 In the current study, when the effects of l-NMMA alone were considered, l-NMMA reduced resting ow by 25%, and similarly reduced peak ow response to exercise by 20%. l-NMMA also reduced hyperemic volume in the recovery period extending 5 minutes after cessation of exercise, by 50%. Nevertheless, when resting ow was maintained during NOS inhibition by coinfusing an endothelium-independent vasodilator, sodium nitroprusside, the reductions in peak ow were not reproduced. Even while maintaining baseline vasodilator tone, however, l-NMMA produced a 21% reduction in the hyperemic volume measured 5 minutes after exercise.
Mechanisms of exercise hyperemia
This result suggests that different mechanisms exist for generation of maximum ow, measured immediately after exercise, and for the more sustained transition period from exercise to rest. This difference may be explained by the increased effect of shear-stress-mediated endothelial NO release in the recovery period. It may also be that other metabolic regulators compensate for NOS inhibition during exercise, but not in recovery. 1 9 ,2 1 The actions of these metabolites might then be re ected in the peak ow measurement, but not thereafter. Additionally, neuronal NOS exists in human skeletal muscle 2 3 and has been shown in animal models to produce NO in response to exercise, thereby relaxing vascular smooth muscle via a cGMPmediated mechanism. 2 4 It may be that neuronal NOS production is not signi cantly inhibited by intravascular administration of l-NMMA at the doses used to inhibit endothelial NOS. 2 5 Limitations A potential limitation of this study is that vessels specically recruited during exercise may not have been subject to NOS inhibition due to the pharmacokinetics of l-NMMA. This problem was minimized by maintaining the l-NMMA infusion for the duration of the exercise protocol, allowing newly recruited vessel beds to be exposed to the drug. In addition, l-NMMA treatment could not be randomized temporally due to its long half-life. The fact that the temporal control study of the exercise stimulus showed no difference from the rst administration to the second somewhat relieves this concern. However, it should be acknowledged that we did not have statistical power to compare directly the differences in responses between the time-control and protocol groups.
Clinical implications
It is clinically important to elucidate the mechanisms of exercise hyperemia. In many disease states, including congestive heart failure and peripheral arterial disease, exercise Vascular Medicine 2002; 7: 163-168 capacity is severely limited. If NO is not a major contributor to exercise hyperemia, efforts should be focused on other metabolic mediators as potential therapeutic targets.
Conclusion
In summary, although the role of NO in maintaining resting vascular tone is generally accepted, its role in improving blood ow to exercising muscles has been debated. In studies of the effect of NOS-inhibition on limb blood ow during exercise in humans, any reductions in ow during exercise have been paralleled by reductions in resting ow. To eliminate the effects of altered vascular tone on exercise hyperemia, the current study maintained resting ow by coinfusing an endothelium-independent vasodilator. When resting vascular tone is maintained, the attenuating effects of l-NMMA on peak exercise hyperemia are eliminated. The effects of l-NMMA are retained, however, for the hyperemic response in the recovery period after exercise. These results indicate that endothelium-derived NO does not contribute signi cantly to the peak blood ow response to exercise in healthy humans, but that it is an important mediator of the transition from exercise to rest.
